PELLEGRINI, CINZIA
PELLEGRINI, CINZIA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
(90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study
2020 Lolli, Ginevra; Argnani, Lisa; Broccoli, Alessandro; Marangon, Miriam; Pellegrini, Cinzia; Morigi, Alice; Casadei, Beatrice; Nanni, Laura; Stefoni, Vittorio; Carella, Matteo; Cavo, Michele; Zinzani, Pier L
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years
2016 Casadei, Beatrice; Pellegrini, Cinzia; Pulsoni, Alessandro; Annechini, Giorgia; De Renzo, Amalia; Stefoni, Vittorio; Broccoli, Alessandro; Gandolfi, Letizia; Quirini, Federica; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, Pier Luigi
A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients
2016 Pellegrini C.; Dodero A.; Chiappella A.; Monaco F.; Degl'Innocenti D.; Salvi F.; Vitolo U.; Argnani L.; Corradini P.; Zinzani P.L.
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma.
2012 Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; Pellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M.
Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients
2013 Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience
2022 Stefoni V.; Argnani L.; Carella M.; Casadei B.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Coppola P.E.; Zinzani P.L.
Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin.
2013 Zinzani PL;Derenzini E;Pellegrini C;Celli M;Broccoli A;Argnani L
Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients
2020 Morigi A.; Argnani L.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; Carella M.; Casadei B.; Sabattini E.; Cavo M.; Zinzani P.L.
Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study
2013 Zinzani P.L.;Pellegrini C.;Merla E.;Ballerini F.;Fabbri A.; Guarini A.;Pavone V.;Quintini G.;Puccini B.;Vigliotti M.L.; Stefoni V.; Derenzini E.;Broccoli A.;Gandolfi L.;Quirini F.;Casadei B.;Argnani L.;Baccarani M.
Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study
2016 Federico, Massimo; Luminari, Stefano; Pellegrini, Cinzia; Merli, Francesco; Pesce, Emanuela Anna; Chauvie, Stephane; Gandolfi, Letizia; Capodanno, Isabella; Salati, Massimiliano; Argnani, Lisa; Zinzani, Pier Luigi
Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial
2017 Zinzani, Pier Luigi; Pellegrini, Cinzia; Chiappella, Annalisa; Di Rocco, Alice; Salvi, Flavia; Cabras, Maria Giuseppina; Argnani, Lisa; Stefoni, Vittorio
Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials.
2013 Zinzani PL;Viviani S;Anastasia A;Vitolo U;Luminari S;Zaja F;Corradini P;Spina M;Brusamolino E;Gianni AM;Santoro A;Botto B;Derenzini E;Pellegrini C;Argnani L
Brentuximab vedotin in the treatment of elderly Hodgkin lymphoma patients at first relapse or with primary refractory disease: a phase 2 study of FIL ONLUS
2020 Stefoni, Vittorio; Marangon, Miriam; Re, Alessandro; Lleshi, Arben; Bonfichi, Maurizio; Pinto, Antonello; Bianchetti, Nicola; Pellegrini, Cinzia; Argnani, Lisa; Zinzani, Pier Luigi
Brentuximab Vedotin in Transplant-Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients
2015 Zinzani, Pier Luigi; Pellegrini, Cinzia; Cantonetti, Maria; Re, Alessandro; Pinto, Antonello; Pavone, Vincenzo; Rigacci, Luigi; Celli, Melania; Broccoli, Alessandro; Argnani, Lisa; Pulsoni, Alessandro
CAR t-cell therapy in BOlogNa–NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON–NEUTRAL): proposed protocol and results from an Italian study
2023 Pensato U.; Amore G.; Muccioli L.; Sammali S.; Rondelli F.; Rinaldi R.; D'Angelo R.; Nicodemo M.; Mondini S.; Sambati L.; Asioli G.M.; Rossi S.; Santoro R.; Cretella L.; Ferrari S.; Spinardi L.; Faccioli L.; Fanti S.; Paccagnella A.; Pierucci E.; Casadei B.; Pellegrini C.; Zinzani P.L.; Bonafe M.; Cortelli P.; Bonifazi F.; Guarino M.
Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report
2021 Lolli G.; Casadei B.; Argnani L.; Pileri A.; Pellegrini C.; Zinzani P.L.
Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial.
2011 Zinzani P.L.; Pellegrini C.; Gandolfi L.; Stefoni V.; Quirini F.; Derenzini E.; Broccoli A.; Argnani L.; Pileri S.; Baccarani M.
Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports.
2013 Broccoli A;Derenzini E;Pellegrini C;Narducci R;Stefani G;Casadei B;Argnani L;Zinzani PL
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia
2022 Broccoli A.; Terragna C.; Nanni L.; Martello M.; Armuzzi S.; Agostinelli C.; Morigi A.; Casadei B.; Pellegrini C.; Stefoni V.; Sabattini E.; Argnani L.; Zinzani P.L.
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection
2023 Pasquini Z.; Toschi A.; Casadei B.; Pellegrini C.; D'Abramo A.; Vita S.; Beccacece A.; Bussini L.; Chionsini M.C.; Dentale N.; Cantiani A.; Lazzarotto T.; Bartoletti M.; Nicastri E.; Zinzani P.; Giannella M.; Viale P.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| (90) Y-ibritumomab tiuxetan in patients with extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) - The Zeno Study | Lolli, Ginevra; Argnani, Lisa; Broccoli, Alessandro; Marangon, Miriam; Pellegrini, Cinzia; Morigi..., Alice; Casadei, Beatrice; Nanni, Laura; Stefoni, Vittorio; Carella, Matteo; Cavo, Michele; Zinzani, Pier L | 2020-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | Br J Haematol - 2020 - Lolli - 90Y‐ibritumomab tiuxetan in patients with extra‐nodal marginal zone B‐cell lymphoma of.pdf |
| 90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years | Casadei, Beatrice; Pellegrini, Cinzia; Pulsoni, Alessandro; Annechini, Giorgia; De Renzo, Amalia;... Stefoni, Vittorio; Broccoli, Alessandro; Gandolfi, Letizia; Quirini, Federica; Tonialini, Lorenzo; Morigi, Alice; Argnani, Lisa; Zinzani, Pier Luigi | 2016-01-01 | CANCER MEDICINE | - | 1.01 Articolo in rivista | cam4.684.pdf |
| A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients | Pellegrini C.; Dodero A.; Chiappella A.; Monaco F.; Degl'Innocenti D.; Salvi F.; Vitolo U.; Argna...ni L.; Corradini P.; Zinzani P.L. | 2016-01-01 | JOURNAL OF HEMATOLOGY & ONCOLOGY | - | 1.01 Articolo in rivista | - |
| A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. | Zinzani P.L.; Tani M.; Pulsoni A.; De Renzo A.; Stefoni V.; Broccoli A.; Montini G.C.; Fina M.; P...ellegrini C.; Gandolfi L.; Cavalieri E.; Torelli F.; Scopinaro F.; Argnani L.; Quirini F.; Derenzini E.; Rossi M.; Pileri S.; Fanti S.; Baccarani M. | 2012-01-01 | ANNALS OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients | Broccoli A;Stanzani M;Bandini G;Bonifazi F;Stefoni V;Pellegrini C;Derenzini E;Gandolfi L;Quirini ...F;Argnani L;Tschon M;Casadei B;Baccarani M;Zinzani PL | 2013-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience | Stefoni V.; Argnani L.; Carella M.; Casadei B.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; ...Nanni L.; Coppola P.E.; Zinzani P.L. | 2022-01-01 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | Stefoni2022_Article_BEGEVSalvageRegimenInRelapsedR.pdf |
| Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin. | Zinzani PL;Derenzini E;Pellegrini C;Celli M;Broccoli A;Argnani L | 2013-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients | Morigi A.; Argnani L.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; ...Carella M.; Casadei B.; Sabattini E.; Cavo M.; Zinzani P.L. | 2020-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study | Zinzani P.L.;Pellegrini C.;Merla E.;Ballerini F.;Fabbri A.; Guarini A.;Pavone V.;Quintini G.;Pucc...ini B.;Vigliotti M.L.; Stefoni V.; Derenzini E.;Broccoli A.;Gandolfi L.;Quirini F.;Casadei B.;Argnani L.;Baccarani M. | 2013-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study | Federico, Massimo; Luminari, Stefano; Pellegrini, Cinzia; Merli, Francesco; Pesce, Emanuela Anna;... Chauvie, Stephane; Gandolfi, Letizia; Capodanno, Isabella; Salati, Massimiliano; Argnani, Lisa; Zinzani, Pier Luigi | 2016-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | e139.full.pdf |
| Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial | Zinzani, Pier Luigi; Pellegrini, Cinzia; Chiappella, Annalisa; Di Rocco, Alice; Salvi, Flavia; Ca...bras, Maria Giuseppina; Argnani, Lisa; Stefoni, Vittorio | 2017-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials. | Zinzani PL;Viviani S;Anastasia A;Vitolo U;Luminari S;Zaja F;Corradini P;Spina M;Brusamolino E;Gia...nni AM;Santoro A;Botto B;Derenzini E;Pellegrini C;Argnani L | 2013-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | haematol.2012.083048.full.pdf |
| Brentuximab vedotin in the treatment of elderly Hodgkin lymphoma patients at first relapse or with primary refractory disease: a phase 2 study of FIL ONLUS | Stefoni, Vittorio; Marangon, Miriam; Re, Alessandro; Lleshi, Arben; Bonfichi, Maurizio; Pinto, An...tonello; Bianchetti, Nicola; Pellegrini, Cinzia; Argnani, Lisa; Zinzani, Pier Luigi | 2020-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | haematol.2019.243170.full.pdf |
| Brentuximab Vedotin in Transplant-Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients | Zinzani, Pier Luigi; Pellegrini, Cinzia; Cantonetti, Maria; Re, Alessandro; Pinto, Antonello; Pav...one, Vincenzo; Rigacci, Luigi; Celli, Melania; Broccoli, Alessandro; Argnani, Lisa; Pulsoni, Alessandro | 2015-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | - |
| CAR t-cell therapy in BOlogNa–NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON–NEUTRAL): proposed protocol and results from an Italian study | Pensato U.; Amore G.; Muccioli L.; Sammali S.; Rondelli F.; Rinaldi R.; D'Angelo R.; Nicodemo M.;... Mondini S.; Sambati L.; Asioli G.M.; Rossi S.; Santoro R.; Cretella L.; Ferrari S.; Spinardi L.; Faccioli L.; Fanti S.; Paccagnella A.; Pierucci E.; Casadei B.; Pellegrini C.; Zinzani P.L.; Bonafe M.; Cortelli P.; Bonifazi F.; Guarino M. | 2023-01-01 | JOURNAL OF NEUROLOGY | - | 1.01 Articolo in rivista | - |
| Clinical Response in Heavily Pretreated Mycosis Fungoides with Pembrolizumab: A Case Report | Lolli G.; Casadei B.; Argnani L.; Pileri A.; Pellegrini C.; Zinzani P.L. | 2021-01-01 | ACTA HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial. | Zinzani P.L.; Pellegrini C.; Gandolfi L.; Stefoni V.; Quirini F.; Derenzini E.; Broccoli A.; Argn...ani L.; Pileri S.; Baccarani M. | 2011-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports. | Broccoli A;Derenzini E;Pellegrini C;Narducci R;Stefani G;Casadei B;Argnani L;Zinzani PL | 2013-01-01 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia | Broccoli A.; Terragna C.; Nanni L.; Martello M.; Armuzzi S.; Agostinelli C.; Morigi A.; Casadei B....; Pellegrini C.; Stefoni V.; Sabattini E.; Argnani L.; Zinzani P.L. | 2022-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | Droplet_HON-40-58.pdf; HON-40-58-s001.jpg; HON-40-58-s002 (1).docx |
| Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection | Pasquini Z.; Toschi A.; Casadei B.; Pellegrini C.; D'Abramo A.; Vita S.; Beccacece A.; Bussini L....; Chionsini M.C.; Dentale N.; Cantiani A.; Lazzarotto T.; Bartoletti M.; Nicastri E.; Zinzani P.; Giannella M.; Viale P. | 2023-01-01 | HEMATOLOGICAL ONCOLOGY | - | 1.01 Articolo in rivista | 2023 Hematological Oncology - 2023 - Pasquini .pdf |